Towards this end, we firstly deprived the human ALL cell line REH of its endogenous STAT6 using CRISPR-Cas9 knockout to assess the possible impact of STAT6 on the chemosensitivity of ALL cells (Fig. 1B). This evidence concerns the gene STAT6 and acute lymphoblastic leukemia.